Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options. At the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), researchers from the Mayo Clinic campus...
Triple Drug Combination Is Promising Option To Treat Metastatic HER2+ Breast Cancer
Potential Detection Of Breast Cancer Spread: New Technique
A new phase III clinical trial of early stage breast cancer patients has shown that a molecule designed to home in on nearby lymph nodes is just as accurate as current techniques, but faster, more specific and easier to use. “These results will really enable molecular biology to enter the operating...
Some Breast Cancer Patients Do Not Benefit From ALN Dissection
A recent observational study of 97,000 women with breast cancer and nodal metastases indicates that there is no appreciable difference in axillary recurrence and survival between those who undergo sentinel lymph node (SLN) biopsy alone versus SLN biopsy with the more invasive completion axillary lymph...
Genes Found To Play A Role In Breast Cancer’s Spread To The Brain
New research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) identifies three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and illuminates the mechanisms by which this spread occurs. The study was published online today in Nature. According...
New Universal Breast Cancer Marker Predicts Recurrence And Clinical Outcome
Reporting online in the American Journal of Pathology, researchers from the Kimmel Cancer Center at Jefferson have implicated the loss of a stromal protein called caveolin-1 as a major new prognostic factor in patients with breast cancer, predicting early disease recurrence, metastasis and breast cancer...
Breast Health Center Gives TGen New Research Opportunities
The opening of a new breast health center next to John C. Lincoln Deer Valley Hospital will provide significant research opportunities for the Translational Genomics Research Institute (TGen). The 9,000-square-foot Breast Health and Research Center will include a tumor biorepository for TGen that will...
Peregrine Pharmaceuticals Completes Patient Enrollment In Its Phase II Trial Of Bavituximab Plus Docetaxel In Breast Cancer Patients
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) announced that it has completed enrollment in its Phase II trial evaluating bavituximab in combination with docetaxel in advanced breast cancer patients. The planned 46 patients have been enrolled and are currently undergoing treatment and follow-up. The...
AVON Foundation Awards $750,000 To Lombardi Cancer Center And The Capital Breast Care Center
What: Georgetown’s Lombardi Comprehensive Cancer Center and Capital Breast Care Center has been awarded $750,000 for its mission of providing breast cancer screening to underserved women at the annual Avon Walk for Breast Cancer in Washington, DC. This is the second year the AVON Foundation has...
Following Intervention To Teach Self-Screening Techniques, Women 10 Times More Likely To Do Breast Self-Exams Correctly
A brief intervention program - consisting of one counseling session and two follow-up phone calls - boosted by tenfold the number of women correctly performing breast self-exams. These are the findings of a Kaiser Permanente Center for Health Research study in the American Journal of Health Promotion. Funded...
Following Intervention To Teach Self-Screening Techniques, Women 10 Times More Likely To Do Breast Self-Exams Correctly
A brief intervention program - consisting of one counseling session and two follow-up phone calls - boosted by tenfold the number of women correctly performing breast self-exams. These are the findings of a Kaiser Permanente Center for Health Research study in the American Journal of Health Promotion. Funded...